Rossari Biotech Ltd · NSE:ROSSARI
Rossari Biotech — Q3 FY2022 Earnings Presentation
14 slides from Rossari Biotech's earnings presentation, Feb 14, 2022
Slide 1: Exchange filing cover letter for Q3 & 9M FY22 earnings presentation
ROSSARI making you more competitive February 14, 2022 DCS-CRD Listing Compliance BSE Limited National Stock Exchange oflndia Ltd. First Floor, New Trade Wing Exchange Plaza, 5th Floor Rotunda Building, Phiroze Jeejeebhoy Towers Plot No.C/1, 'G'Block, Bandra- Kurla Complex Dalal Street, Fort Mumbai 4
Slide 2: Rossari Biotech Limited Q3 & 9M FY22 Results Presentation
® ROSSARI making you mor,e·competitive Rossari Biotech Limited Q3 & 9M FY22 Results Presentation February 14, 2022
Slide 3: Disclaimer
® Disclaimer ROSSARI making you more competitive Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd (Rossari) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticip
Slide 4: Q3 & 9M FY22 Results Overview
" ROSSARI making you more competitive Q3 & 9M FY22 Results Overview 3
Slide 5: Q3 FY22 – Key Financial Highlights
® Q3 FY22 – Key Financial Highlights ROSSARI making you more competitive Revenue from Operations EBITDA PAT (Rs. crore) (Rs. crore) (Rs. crore) 428.4 46.7 26.2 22.5 384.5 44.0 21.6 34.0 210.0 Q2 FY22 Q3 FY21 Q3 FY22 Q2 FY22 Q3 FY21 Q3 FY22 Q2 FY22 Q3 FY21 Q3 FY22 Shift % (Y-o-Y) 104% 37% 5% Shift %
Slide 6: Management Message
<I!) Management Message ROSSARI making you more competitive Commenting on the performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We have delivered steady performance during the quarter despite a challenging i
Slide 7: Key Developments
® Key Developments ROSSARI making you more competitive Integration of Romakk Chemicals successfully completed • Rossari acquired 50.1% stake of Romakk Chemicals Pvt Ltd w.e.f. December 01, 2021. Accordingly, this has been consolidated as JV in Q3 FY22 results • Romakk has been delivering encouraging
Slide 8: Abridged P&L Statement - Consolidated
® Abridged P&L Statement - Consolidated ROSSARI making you more competitive Y-o-Y Change Y-o-Y Change Particulars (Rs. crore) Q3 FY22 Q3 FY21 9M FY22 9M FY21 (%) (%) Revenues from Operations 428.4 210.0 104.0% 1044.0 491.1 112.6% Total Expenditure • COGS 321.6 139.8 130.0% 780.6 311.6 150.5% • Emplo
Slide 9: Q3 FY22 - Segment-wise Details
® Q3 FY22 - Segment-wise Details ROSSARI making you more competitive Segment-wise Revenue Break-up (Rs. crore) ■ Q3 FY21 ■ Q2 FY22 ■ Q3 FY22 305.24 236.1 119.6 109.7 102.8 78.2 38.7 20.38 12.2 HPPC TSC AHN Shift (Y-o-Y) % 155.2% 31.5% 67.0% Shift (Q-o-Q) % 29.3% -6.3% -47.3% Note: 1) All figures, un
Slide 10: Q3 FY22 - Financial and Operational Discussions (Y-o-Y)
® Q3 FY22 - Financial and Operational Discussions (Y-o-Y) ROSSARI making you more competitive Net Revenues Q3 FY22 Revenues from operations stood at Rs. 428.4 crore, higher by 104.0% YoY ➢ Stable growth witnessed across businesses ➢ HPPC business reported healthy sales supported by stable traction i
Slide 11: Annexure
ROSSARI making you more competitive Annexure 10
Slide 12: Conference Call Details
® Conference Call Details ROSSARI making you more competitive ,, ,, ---------------------------------------------------------------- - , , ... ... , , ,, '' I I '' I I Q3 & 9M FY22 Earnings Conference Call \ I Time • 5:30 p.m. IST on Tuesday, February 15, 2022 To enable participants to connect to th
Slide 13: About Us
® About Us ROSSARI making you more competitive Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a For further information, please contact: Speciality-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, Indi
Slide 14: Thank you
® ROSSARI making you more competitive Thankyt,u 13